Author

Thiago Trovati Maciel

InsermORCID 0000-0002-9347-981XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Olivier HermineiD· 2 shared Achille AoubaiD· 1 shared Alexandra Audemard‐VergeriD· 1 shared Alexis MathianiD· 1 shared Annalisa SantiniiD· 1 shared Annarita MiccioiD· 1 shared Antoine NéeliD· 1 shared Arsène MEKINIANiD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

Olivier HermineORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

VEXAS anemia is a mosaic erythroblastopenia

François Rodrigues, Giulia Hardouin, Sara El Hoss, Aya Ghoul, Emilie‐Fleur Gautier, Michaël Dussiot, Maria A. Lizarralde-Iragorri, Annalisa Santini, Sandy Peltier, Pascal Amireault, Vanessa Soldan, Annarita Miccio, Mounia Debili, Vincent Jachiet, Thiago Trovati Maciel, , Jean‐David Bouaziz

This study investigates VEXAS anemia, showing that UBA1 mutations affect erythroblast differentiation but not mature red cells, leading to a mosaic erythroblastopenia.

Blood · Sep 19, 2025Peer-reviewedCell Biology

Therapeutic potential of oxygen through M101 transportation in reducing vaso-occlusion and hemolysis in a mouse model of sickle cell disease.

Franck Zal, Rachel Rignault‐Bricard, Leïla Demini, Benoı̂t Barrou, Laurent Alexandre Lantieri, Olivier Hermine, Jean‐Benoît Arlet, Thiago Trovati Maciel

This study evaluates M101, a marine-derived hemoglobin-based oxygen carrier, in a mouse model of sickle cell disease, showing reduced RBC sickling, hemolysis, and vaso-occlusion.

bioRxiv · Jun 18, 2025 · PreprintPathology